Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island.

Slides:

Advertisements

Similar presentations

Patient enrollment DIAS-4 vs. Endovascular Therapy

Advertisements

3/28/2017© 2009, American Heart Association. All rights reserved.

Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D. Hill.

Protecting the heart and the kidney: Implications from the SHARP trial Dr. Christina Reith University of Oxford United Kingdom.

Beyond the Basics of Stroke Evaluation

Disclosures: Maximo C. Kiok, M.D. Medical Director of Stroke Program Trinity Health System.

The Mid America Brain and Stroke Institute Kansas City, Missouri M A B S I.

Ann M. Hoff, MD ETC Physician Trinity Health. American Stroke Association  Guidelines for the Early Management of Adults with Ischemic Stroke (2007)

The Future of Stroke James D. Fleck, M.D. Medical Director IU Health Methodist Hospital Comprehensive Stroke Center.

FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4

Diagnostic and Therapeutic Options for Emergency Stroke Care: Perspectives from the US, Italy, and Developing Countries Andrew W. Asimos, MD Director of.

Primary PCI Treatment of choice for Acute MI.

The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,

A stroke is the leading cause of permanent impairment and disability. Pending a radical cure, patients recovering from a stroke will continue to require.

Interventional Stroke Treatment 2015

European Stroke intervention Guidelines ESMINT/ESO/ESNR/EAN WLNC 2015

Endovascular Therapy for Acute Ischemic Stroke ML006 Rev01.

UDATE ON REVASCAT: (Randomized Trial Of Revascularization With Solitaire FR® Device Versus Best Medical Therapy In The Treatment Of Acute Stroke Due To.

Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.

Overview of new acute stroke trials Shawna Cutting, MD, MS Rush University Medical Center June 9, 2015.

The Acute Stroke Menu: Something off the Back Page Innovative ways to use IV t-pa and other assorted therapies available outside the standard treatment.

Critical Appraisal Athar Yasin EOE - RTD Jan 2012.

Acute Ischemic Stroke Treatments Patrick J. Ward, PA-S.

EXERCISE AFTER STROKE Specialist Instructor Training Course L3 Stroke: the first few days Prof. Gillian Mead Reader and Consultant The University of Edinburgh.

What is the outcome of Door-to-needle Time within 60minutes for acute ischemic stroke patients treat with t-PA? Chi-Ching Chen 1, Hui-Fen Huang 1, Yu-Ling.

Case Report Evan Leibner, MD, PhD Emergency Medicine, PGY 3 Stony Brook University Medical Center.

A multimodal step-up approach as rescue therapy of ischemic stroke L. Verganti, S. Vallone, C. Moratti, M. Malagoli, P. Carpeggiani Department of Neuroscience,

Kim, Sun-Yong, M.D. Department of Radiology Ajou University Hospital, Suwon, Korea AGGRESIVE MECHANICAL CLOT DISRUPTION FOR ACUTE ISCHEMIC STROKE WITH.

Annual Patient Admissions for Acute Coronary Syndromes 1.4 MM Non-ST elevation ACS 0.6 MM ST-elevation MI ~ 2.0 MM patients admitted to CCU or telemetry.

MR CLEAN Multicenter Randomized CLinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands C.B. Majoie, Y.B. Roos, A. van der.

Time Is Brain: Advanced Stroke Treatment Grahame C Gould, MD Jefferson Neurosurgical Associates at Main Line Health, Bryn Mawr Hospital Division of Neurovascular.

ACUTE TREATMENT OF STROKE: RECENT ADVANCES AND PERFORMANCE AT CAMPBELLTOWN ALEX BUTTFIELD ED STAFF SPECIALIST.

Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Thrombectomy for Acute Ischemic Stroke:

ACUTE STROKE TREATMENT: An introduction Dec.2014

Chapter 35 Stroke. Stroke: occurs when blood flow to the brain is interrupted by a clot in a artery or other vessel. When this occur brain cells begin.

Stent-assisted Mechanical Recanalization for Treatment of Acute Intracerebral Artery Occlusion C. Roth ‡, P. Papanagiotou ‡, S. C.

Treating Acute Ischemic Stroke, Can We Open Up the Time Window？

Copyright © 2005 American Medical Association. All rights reserved.

A stroke is the leading cause of permanent impairment and disability

From: Intra-arterial Prourokinase for Acute Ischemic StrokeThe PROACT II Study: A Randomized Controlled Trial JAMA. 1999;282(21): doi: /jama

Direct Carotid Access for Acute Stroke Intervention

Direct catheter-based thrombectomy in acute ischemic stroke

Thrombectomy in Acute Stroke

Sameer A. Ansari, MD, PhD Associate Professor

Acute Carotid Occlusions

Critical Care Management of Stroke

CAS in acute stroke C. Roth‡, P. Papanagiotou‡, A. M. Politi‡, K. W. Reith‡ Department of diagnostic.

Cardiovascular Research Technology Conference (CRT 17)

Mechanical thrombectomy

Acute Ischemic Stroke Yousef Mohammad MD., MSc., FAHA

Multimodal 3 Tesla MRI Confirms Intact Arterial Wall in Acute Stroke Patients After Stent-Retriever Thrombectomy by Kety Hsieh, Rajeev K. Verma, Gerhard.

The New Frontier In Stroke Care – Endovascular Intervention

International Journal of Surgery

Acute Ischemic Stroke First Eight Hours Dr. Mohammed Ateequr Rahman

Volume 14, Issue 5, Pages (May 2015)

ANTARCTIC Trial design: Patients with acute coronary syndrome undergoing stenting were randomized to tailored antiplatelet therapy (n = 435) versus conventional.

Modified Rankin score 0-2

ECASS-II: intravenous alteplase in acute ischaemic stroke

Thrombolysis for acute ischemic stroke

Extended Window Thrombectomy

Volume 14, Issue 5, Pages (May 2015)

Figure 1 Endovascular treatment in acute ischaemic stroke

Update from education committee

Volume 12, Issue 8, Pages (August 2013)

Three outcome measures from the NINDS tPA trial

DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.

MOMENTUM 3 Trial design: Patients with advanced heart failure were randomized to a centrifugal-flow pump (n = 152) vs. an axial-flow pump (n = 142). Results.

Update from education committee

STROKE AWARENESS MONTH

Presentation transcript:

Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island

Objectives Review the symptoms of a stroke Discuss why strokes occur Describe the use of the Solitaire device to treat a stroke

Symptoms of Stroke

What Causes a Stroke?

Treatment Options for Stroke Time from symptom onset – < 3 or < 4.5 hours – “clot buster” medication tPA (Alteplase) – Greater than 4.5 hours OR ineligible for tPA Mechanical thrombectomy – Up to 8 hours from symptom onset

Finding the Clot Normal AngiographyAngiography showing a Stroke

Solitaire in Action

Solitaire Device TS5Y TS5Y

Effectiveness of Solitaire Device SWIFT TRIAL Solitaire DeviceMerci Retriever Recanalization Rates 61%24% Good Neurological Outcomes at 90 Days 58%33% 90 Day Mortality17%38%

1.)“Solitaire FR Revascularization Device” Covidien. 27 Feb )Saver, JL Jahon R, Levy EI. Solitaire flow restoration device versus the Merci Retreiver in patients with acute ischaemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial. The Lancet, 380(9849), )“About Stroke” American Stroke Association. 27 Feb References: